Financing

MedMira closes $3.25 million private placement

Published in AIDS Weekly, July 22nd, 2002

MedMira, Inc., announced that it has completed a private placement financing originally announced in a press release dated May 14, 2002. As announced, the private placement involved the issuance of 2,500,000 common shares at $1.30 per share and warrants to purchase 1,250,000 common shares for a 1 year period at a purchase price of $2.00 per share.

The private placement was concluded directly by MedMira in reliance upon applicable securities exemptions. The 2,500,000 common shares issued are subject to a 4-month hold period.

"MedMira is poised to capture short-term profitability and long term success," said Stephen Sham, chairman and CEO of MedMira. "The results...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2002-07-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry